We offer end to end service for the API industry
by contract research, development and manufacturing products
across the drug development spectrum with the basic key starting
materials,intermediates and API to facilitate our partners for the effective
commercialization of the product globally.
Mekanar Pharma is end-to-end contract research, development, and manufacturing organization (CRO-CDMO) offering products and services across the drug development spectrum to enable our partners to turn their concepts into commercials along with API development with a full range of developing our own analytical methods and protecting the process by filing patents.
We work with global pharma companies to accelerate the discovery, development and manufacture of complex small molecules, consistently delivering values based on quality, responsiveness, and transparency. Our development is tailor made and will be on a cost competitive edge wrt the API global prices.
Mekanar Pharma is established in 2022. We are young, dynamic and fast-growing Active Pharmaceutical Ingredient (API) company, headquartered in Hyderabad, India.
Our ability to offer end-to-end solutions and support standalone programs is derived from our experienced team, enabling technologies, and a partnership approach to every engagement. Our services offer a list of comprehensive programs from materials management and API sourcing to development, manufacturing, regulatory support, and packaging.
To be a trusted and reliable global outsourcing partner for contract research, development, manufacturing of pharmaceutically active ingredients by maintaining integrity, transparency & flexibility on all levels of the organization.
To supply affordable and quality services along with APIs/Intermediates to global partners by following high cGMP manufacturing quality standards along with respective CMC data.
Our core values are:
We want to be recognized for the excellent client service with quick turn-around time from R&D level to Manufacturing level. We keep our customer needs at the center of all our decisions. By providing flexible, integrated, end-to-end services, we give our customers effective and timely solutions with collaborative and transparent approach at every stage of business.
Positioning ourselves with the niche product portfolio, to be recognized for the complexity and the variation involved in the technology. We wish to be the early adopters of technology in all possible phases of our business lifecycle, ensuring to reach and sustain our position in the market.
Operate with highest degree of integrity and with
uncompromised transparency.
Our commitment lies not only to our customers, but also to our team members and the environment. We strongly believe in conducting ethical, socially responsible behaviour for long term sustainability and mutual benefit of all parties involved.
Our ability to offer end-to-end solutions or support standalone programs is derived from our experienced team, enabling technologies, and a partnership approach to every engagement. Our services offer a list of comprehensive programs from materials management and API sourcing to development, manufacturing, regulatory support, DMF filing in various market segments and Patent filing for the processes developed.
We have the expertise, capabilities, and infrastructure to safely and securely synthesize and manufacture intermediates, APIs, and other products to cGMP. We can support you with cost-effective scale-up options for projects from milligram research scale to pilot and manufacturing level requirements.
